ISMIE - News and Articles

10/24/23

Telemedicine Flexibilities Pertaining to Controlled Substances Extended Again!

Now the DEA and the Department of Health and Human Services have initiated a Second Temporary Rule to extend the expiration date to Dec. 31, 2024.

View

05/16/23

DEA Extends Telehealth Flexibility Pertaining to Controlled Substances

A pandemic-era policy that allows physicians to prescribe controlled substances in a telehealth visit has been extended to Nov. 11, 2023.

View

02/07/23

Free 18-Month Program Aims to Improve Cancer Diagnostics Via Telemedicine

To learn more, register for one of AHRQ’s informational webinars, available on numerous dates and times through May 2023.

View

10/05/21

Telemedicine Use Simmering Down After Explosive Increase

ISMIE offers a helpful primer on telemedicine for policyholders that outlines the key risk management considerations.

View